ANTABIO

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-07-30
Last Posted Date
2024-08-21
Lead Sponsor
Antabio
Target Recruit Count
48
Registration Number
NCT06527677
Locations
🇩🇪

CRS Clinical Research Services Kiel GmbH, Kiel, Germany

FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects

First Posted Date
2023-06-15
Last Posted Date
2024-03-15
Lead Sponsor
Antabio
Target Recruit Count
72
Registration Number
NCT05905913
Locations
🇫🇷

Biotrial, Rennes, France

© Copyright 2024. All Rights Reserved by MedPath